Skip to main content

Table 1 Patient characteristics and descriptive statistics

From: Long-term survival and prognostic factors for locally advanced renal cell carcinoma with renal vein tumor thrombus

Variable All patients (n = 128)
Median Age, years (range) 61.0 (34.0–87.0)
Sex, n (%)
 Male 103 (80.5)
 Female 25 (19.5)
Median Body Mass Index (BMI), Kg/m2 (range) 24.7 (17.1–35.9)
Laterality, n (%)
 Right 60 (46.9)
 Left 68 (53.1)
Clinical Symptoms, n (%)
 Hematuria 53 (41.4)
 Osphyalgia 17 (13.3)
 Paraneoplastic Syndrome
 (Fever, Anemia, Hypercalcemia, Emaciation)
18 (14.1)
 Asymptomatic 55 (42.9)
MaximumTumor Size, cm (range) 7.4 (2.7~19.0)
Perirenal Fat Invasion, n (%)
 Yes 52 (40.6)
 No 76 (59.4)
Tumor Necrosis, n (%)
 Yes 33 (25.8)
 No 95 (74.2)
pN+, n (%)
 Yes 9 (7.0)
 No 121 (93.0)
Pathological Type, (%)
 Clear Cell Carcinoma 126 (98.4)
 Chromophobe Cell Carcinoma 1 (0.8)
 Type II Papillary Cell Carcinoma 1 (0.8)
Fuhrman Grade (Clear Cell Carcinoma), n (%)
 G1 7 (5.6)
 G2 46 (36.5)
 G3 52 (41.3)
 G4 21 (16.6)
Sarcomatoid Differentiation, n (%)
 Yes 26 (20.8)
 No 102 (79.2)
Friable RVTT, n (%)
 Yes 23 (18.0)
 No 105 (82.0)
Median Bleeding Volume, ml (range) 150 (30~4000)
Median Volume of Blood Transfusion, ml (range) 1200 (200~4500)
Postoperative Adjuvant Therapy, n (%)
 Cytokine or Targeted Therapy 60 (46.9)
 Active surveillance 68 (53.1)
Postoperative Local Recurrence/Metastasis, n (%)
 Lung Metastasis 39 (30.5)
 Bone Metastasis 7 (5.5)
 Local Recurrence 4 (3.1)
 Thyroid Metastasis 2 (1.6)
 Brain Metastasis 1 (0.8)
 Scalp Metastasis 1 (0.8)
 Abdominal Wall Metastasis 1 (0.8)
 Lymph Node Metastasis 1 (0.8)
 Multiple Organ Metastasis 3 (2.3)